gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Laney, V; Li, Y; Lu, ZR | 1 |
| Chen, C; Chen, Z; Cheng, X; Dai, J; Guo, Y; He, Y; Huang, G; Huang, T; Lin, X; Ouyang, D; Rozhkova, EA; Ruan, J; Song, S; Wang, Q; Wu, M; Xie, J; Yang, H | 1 |
| Adriouach, S; Allémann, E; Chauvin, AS; Crowe, LA; Lenglet, S; Thomas, A; Vorobiev, V | 1 |
| Dong, L; Du, W; Hai, Z; Liang, G; Qian, J; Xu, J; Zhong, K | 1 |
| Deng, K; Huang, SW; Li, XQ; Li, YS; Liao, RF; Lu, ST; Wan, B; Wu, B; Wu, BL; Xu, HB | 1 |
| Bolze, F; Bonnet, CS; Heitz, V; Jenni, S; Pallier, A; Schmitt, J; Sour, A; Tóth, É; Ventura, B | 1 |
| Chen, S; Hwang, DW; Li, H; Liu, M; Xie, J; Yang, Y; Yuan, Y; Zhang, A; Zhang, Z; Zhou, X | 1 |
| Gao, J; Huang, J; Li, A; Lin, H; Richmond, J; Sun, C; Yang, Z | 1 |
| Chang, JC; Chien, YH; Ho, HY; Ho, WY; Huang, CC; Hung, ST; Liau, MC; Su, CH; Yeh, CS | 1 |
| Ananta, JS; Decuzzi, P; Ferrari, M; Gizzatov, A; Guven, A; Liu, X; Ramirez, M; Sethi, R; Shen, H; Sood, A; Stigliano, C; Wilson, LJ; Xu, R | 1 |
| Chen, J; Gao, Y; Gu, J; Li, Y; Liu, X; Niu, D; Shi, J; Shi, P; Zhou, L; Zhu, S | 1 |
| Chen, S; Li, H; Liu, M; Ren, L; Ye, C; Zhang, Z; Zhou, X | 1 |
| Jeong, EK; Kaneshiro, TL; Lu, ZR; Morrell, G; Parker, DL | 1 |
| Aime, S; Barge, A; Cabella, C; Cravotto, G; Geninatti Crich, S; Stefania, R; Szabo, I; Tei, L | 1 |
| Amano, H; Harada, H; Hiraoka, M; Kimura, H; Kimura, S; Makino, A; Okada, T; Saji, H | 1 |
| Ahmad, A; Bell, JD; Herlihy, AH; Jorgensen, MR; Kalber, T; Kamaly, N; Miller, AD; Oliver, MH; So, PW | 1 |
16 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Neoplasms
| Article | Year |
|---|---|
Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Topics: Amino Acids; Animals; Contrast Media; Fibrin; Fibronectins; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Molecular Imaging; Neoplasms; Oncogene Proteins; Organometallic Compounds; Peptides; Tumor Microenvironment | 2022 |
Dual-Responsive Turn-On T
Topics: Cell Line, Tumor; DNA, Catalytic; Heterocyclic Compounds; Nanoparticles; Neoplasms; Oligonucleotides; Oligonucleotides, Antisense; Organometallic Compounds; Phototherapy | 2023 |
Vascular-targeted micelles as a specific MRI contrast agent for molecular imaging of fibrin clots and cancer cells.
Topics: Cell Line; Contrast Media; Fibrin; Fluorescent Dyes; Heterocyclic Compounds; Human Umbilical Vein Endothelial Cells; Humans; Intravital Microscopy; Magnetic Resonance Imaging; MCF-7 Cells; Micelles; Molecular Imaging; Neoplasms; Organometallic Compounds; Phosphatidylethanolamines; Plaque, Atherosclerotic; Polyethylene Glycols | 2021 |
Alkaline Phosphatase-Instructed Self-Assembly of Gadolinium Nanofibers for Enhanced T
Topics: Alkaline Phosphatase; Animals; Contrast Media; Gadolinium; HeLa Cells; Heterocyclic Compounds; Humans; Hydrogels; Magnetic Resonance Imaging; Mice, Inbred BALB C; Nanofibers; Neoplasms; Oligopeptides; Organometallic Compounds; Phantoms, Imaging | 2017 |
Near-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapy.
Topics: Animals; Contrast Media; Female; Heterocyclic Compounds; Humans; Indocyanine Green; Infrared Rays; Liposomes; Magnetic Resonance Imaging; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Neoplasms; Neoplasms, Experimental; Organometallic Compounds; Phototherapy; Signal-To-Noise Ratio; Theranostic Nanomedicine | 2017 |
A Porphyrin Dimer-GdDOTA Conjugate as a Theranostic Agent for One- and Two-Photon Photodynamic Therapy and MRI.
Topics: Dimerization; HeLa Cells; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Neoplasms; Organometallic Compounds; Photochemotherapy; Photons; Photosensitizing Agents; Porphyrins; Singlet Oxygen; Theranostic Nanomedicine | 2018 |
Engineered Paramagnetic Graphene Quantum Dots with Enhanced Relaxivity for Tumor Imaging.
Topics: Chelating Agents; Contrast Media; Gadolinium; Graphite; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Nanostructures; Neoplasms; Organometallic Compounds; Quantum Dots; Water | 2019 |
A gadolinium-complex-based theranostic prodrug for in vivo tumour-targeted magnetic resonance imaging and therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Drug Carriers; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Organometallic Compounds; Prodrugs; Signal-To-Noise Ratio; Theranostic Nanomedicine; Transplantation, Heterologous | 2019 |
Tumor targeting and MR imaging with lipophilic cyanine-mediated near-infrared responsive porous Gd silicate nanoparticles.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Endocytosis; Fibroblasts; Fluorescence; Gadolinium; Heterocyclic Compounds; Humans; Indocyanine Green; Lipids; Magnetic Resonance Imaging; Mice; Mice, SCID; Nanoparticles; Neoplasms; Organ Specificity; Organometallic Compounds; Porosity; Propylamines; Silanes; Silicates; Spectroscopy, Near-Infrared; Time Factors | 2013 |
Geometrical confinement of Gd(DOTA) molecules within mesoporous silicon nanoconstructs for MR imaging of cancer.
Topics: Contrast Media; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Molecular Structure; Nanoparticles; Neoplasms; Organometallic Compounds; Porosity; Silicon | 2014 |
Multifunctional gold nanostar-based nanocomposite: Synthesis and application for noninvasive MR-SERS imaging-guided photothermal ablation.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Gold; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mice, Inbred BALB C; Nanocomposites; Neoplasms; Organometallic Compounds; Organosilicon Compounds; Phototherapy; Polyethylene Glycols; Spectrum Analysis, Raman | 2015 |
MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Contrast Media; Drug Carriers; Fluorescent Dyes; Heterocyclic Compounds; Humans; Liposomes; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Nanostructures; Neoplasms; Oligopeptides; Organometallic Compounds; Paclitaxel; Polyethylene Glycols; Radiography; Transplantation, Heterologous | 2015 |
Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
Topics: Amides; Animals; Cell Line, Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Mice; Mice, Nude; Molecular Conformation; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds | 2008 |
Tuning glutamine binding modes in Gd-DOTA-based probes for an improved MRI visualization of tumor cells.
Topics: Animals; Contrast Media; Cyclization; Glutamine; Hepatocytes; Heterocyclic Compounds; Magnetic Resonance Imaging; Neoplasms; Organometallic Compounds; Rats; Tumor Cells, Cultured | 2009 |
Effective encapsulation of a new cationic gadolinium chelate into apoferritin and its evaluation as an MRI contrast agent.
Topics: Animals; Apoferritins; Cations; Chelating Agents; Contrast Media; Coordination Complexes; Heterocyclic Compounds; Magnetic Resonance Imaging; Mice; Nanocapsules; Neoplasms; Organometallic Compounds | 2011 |
Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging.
Topics: Cell Death; HeLa Cells; Heterocyclic Compounds; Humans; L-Lactate Dehydrogenase; Ligands; Lipids; Liposomes; Magnetic Resonance Imaging; Microscopy, Fluorescence; Neoplasms; Organometallic Compounds; Spectrophotometry, Atomic; Transfection | 2008 |